Otologic Pharmaceutics, Inc.

Company

Original commercial developer of NHPN-1010, an oral otoprotectant combining HPN-07 and N-acetylcysteine, via its subsidiary Auditus LLC. Licensed the underlying technology from the Hough Ear Institute and Oklahoma Medical Research Foundation in 2010.